Lice infestations
Drug research and approvals for lice infestations: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 2 studies of lice infestations are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 2
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- Safety, Efficacy and Preventative Effect of a Head Lice Product (X92001483) vs. Nix Creme Rinse (1% Permethrin).NCT07660354 · Not applicable · Oystershell NV · starts May 1, 2026
- Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing ShampooNCT07191457 · Not applicable · Oystershell NV · starts Oct 2, 2025
Approved 4
- IvermectinGlutamate-gated chloride channel modulator
- SpinosadNicotinic acetylcholine receptor agonist
- AbametapirMetalloproteinase inhibitor
- Benzyl alcohol
Phase 3 3
- PermethrinVoltage-sensitive sodium channel blocker
- MalathionAcetylcholinesterase inhibitor
- Coco diethanolamide
Phase 2 1
- LindaneGABA-A receptor negative allosteric modulator
Phase 1 or earlier 2
- Sodium lauryl sulfate
- MoxifloxacinTopoisomerase IV inhibitor
How its trials ended
57 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 15 whose ending is known, 80% met their primary endpoint, 0% missed it and 20% stopped early.
- Completed, result not reported3561%
- Met its primary endpoint1221%
- Status unknown47%
- Ongoing35%
- Stopped: lack of efficacy24%
- Stopped: enrollment or feasibility12%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA